Semaglutide is now approved for T2D patients with CKD, reducing cardiovascular and kidney disease risks. The FLOW phase 3b trial showed significant reductions in adverse kidney and cardiovascular ...

Chronic kidney disease (CKD) is marked by the gradual loss of kidney function, which means the kidneys cannot filter waste and regulate water and acid in the blood as well as they should. Early in the ...

FRIDAY, Jan. 17, 2025 (HealthDay News) -- Tea consumption offers protective effects on mortality among patients with chronic kidney disease (CKD), according to a study published online Jan. 13 in ...

Following the continous increase on the number of people with chronic kidney disease ( CKD) a dialysis unit (renal centre) has been established at David Umahi Federal university of Health science, ...

A Phase 3 clinical trial found that injections of the semaglutide medication once weekly reduced the risk of kidney disease worsening by 24% in people who also had diabetes. It also reduced the ...

Researchers conducted a retrospective study to synthesize the literature on the illness experience of people with CKD undergoing maintenance dialysis. They followed PRISMA and PiCO guidelines for the ...

Chronic Kidney Disease (CKD ... this age group than optimizing dialysis management alone[1]. Another significant focus has been on shared decision-making among older adults with advanced CKD.

The final, formatted version of the article will be published soon. Chronic kidney disease (CKD) is commonly associated with vascular injury. To rapidly evaluate microcirculation in non-dialysis CKD ...

Chronic kidney disease (CKD) is an umbrella term used to describe a longstanding disease or condition that causes the progressive loss of kidney (renal) function. Symptoms vary, depending on the stage ...

Cardiovascular diseases such as stroke are a major cause of morbidity and mortality for patients with chronic kidney disease (CKD). The underlying mechanisms connecting CKD and cardiovascular disease ...